RTI Health Solutions

@RTIHS

From clinical to post-market - integrated and services for and . Unit of . Non-profit. Like/RT≠Endorsement

USA-Spain-Sweden-UK-France
Vrijeme pridruživanja: prosinac 2012.

Tweetovi

Blokirali ste korisnika/cu @RTIHS

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RTIHS

  1. prije 9 sati

    How do we place a value on indirect treatment benefits like quality of life when valuing medical treatments and determining health care coverage? New research.

    Poništi
  2. prije 13 sati

    See new research on the best ways to ensure respondent question comprehension in discrete-choice experiment surveys.

    Poništi
  3. prije 16 sati

    What are key challenges to developing cost-effectiveness models in rare diseases? Here's a recorded webinar about these challenges and overcoming them.

    Poništi
  4. 4. velj

    Don't let the EU MDR recertification deadline catch you out in the cold. Learn how our researchers can help.

    Poništi
  5. 3. velj

    Congratulation Caroline (and coauthors)! The most downloaded article of 2019 in with over 7K downloads - a review of discrete choice experiments by et al.

    Poništi
  6. 3. velj

    Congratulation Caroline (and coauthors)! The most downloaded article of 2019 in with over 7K downloads - a review of discrete choice experiments by et al.

    Poništi
  7. 3. velj

    Want to learn more about patient preference methods & studies? Join Brett Hauber, VP of Health Pref at & Deborah Marshall of the U of Calgary in a webinar hosted by ISPOR. Learn more.

    Poništi
  8. 3. velj

    If you want to get your cell or to patients as quickly as possible, don't wait until after regulatory approval to develop your strategic plan.  

    Poništi
  9. 31. sij
    Poništi
  10. 30. sij

    Here's info on the latest AMCP & FDA guidance for drug & medical device developer pre-approval submissions. Downloadable 'at-a-glance' infographic.

    Poništi
  11. 30. sij

    Join Brett Hauber and other speakers for this ISPOR-FDA Summit on in regulation, in-person or virtually.

    Poništi
  12. 30. sij

    Research on Early dialogue with NICE and EUnetHTA: a UK perspective in a politically uncertain era.

    Poništi
  13. proslijedio/la je Tweet
    29. sij

    Our guidance says that health and wellbeing at work should be an organisational priority. To implement our own recommendations we've been taking part in healthy work week! We've had running clubs, mindfulness sessions and more! See our guidance here:

    NICE's healthy work week
    Poništi
  14. 29. sij

    Our researchers are happy to show you how our integrated project teams can partner with you to help you get the most out of your real-world evidence.

    Poništi
  15. proslijedio/la je Tweet
    29. sij

    Emily’s tips for tranquil travel can help ease stress related to air travel for people living with and their care partners. via

    Poništi
  16. 29. sij

    The EU Medical Device Recertification deadline is coming. Are you ready? We are, and we've got your back. Learn how we can help you prepare.

    Poništi
  17. 29. sij

    "Parents may now have a choice between general or local anesthesia when children need ear tubes" Carol Mansfield, RTIHS Health Preference expert.

    Poništi
  18. proslijedio/la je Tweet
    28. sij
    Poništi
  19. proslijedio/la je Tweet

    NIMH has funding opportunities focused on enhancing suicide prevention in emergency care via telehealth, as well as addressing research gaps. Applications are all due by February 10, 2020: [] [] []

    Poništi
  20. proslijedio/la je Tweet
    28. sij

    CORONAVIRUS UPDATE: Today at 11:15 AM ET, join , , & ’s Director Anthony Fauci for an update on the HHS response to the Novel Coronavirus. Watch live on HHS Twitter.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·